Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D is crucial for skin health and managing skin diseases.

Herbal nano-formulations show potential for effective skin delivery but need more research.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Animal research has greatly advanced dermatology.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Natural products like propolis are causing more skin allergies, and certain skin treatments and medications have various side effects and risks.

Topical tacrolimus is safe and effective for skin conditions, but oral tacrolimus has serious side effects.

Scalp itching is common and hard to diagnose due to the complex nerve structure of the scalp.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Patients with skin diseases rated psychological effects as most impactful, needing a treatment approach that addresses both mind and body.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Wnt signaling is crucial for skin wound healing and reducing scars.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.